Get the tools used by (smart)2 investors.
SP500 -2.1%DOW -1.8%FTSE 100 -0.1%NIKKEI -1.0%OIL -0.7%GOLD 0.8%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

EBITDA Forecast Consensus Standard Deviation for Insulet Corporation

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PODD: Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...

256.19 USD
Price
– USD
Fair Value
–
Upside
160.19 - 289.46
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Insulet Corporation's EBITDA Forecast Consensus Standard Deviation:

Dec 2026Dec 2028Dec 2030Dec 2032Dec 20340 K10 M20 M30 M40 M
Performance Summary
  • Insulet's ebitda forecast consensus standard deviation for the next fiscal year is 23.207 million
  • Insulet's ebitda forecast consensus standard deviation is expected to average 27.723 million over the next 5 fiscal years.
  • Insulet's is expected to deliver median ebitda forecast consensus standard deviation of 25.141 million over the next 5 fiscal years.

How does Insulet's EBITDA Forecast Consensus Standard Deviation benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Insulet Corporation because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Insulet EBITDA Forecast Consensus Standard Deviation Benchmarks
NameTickerEBITDA Forecast Consensus Standard Deviation
Paragon 28 IncNYSE:FNA0 K
Neuroone Medical Technologies CorpNASDAQCM:NMTC0 K
Milestone ScientificNYSEAM:MLSS-
Retractable Technologies IncNYSEAM:RVP-
Precision Optics Corporation IncNASDAQCM:POCI-
HealthcareSECTOR:HLTH.US527.681 K
Orthopediatrics CorpNASDAQGM:KIDS600.79 K
Embecta CorpNASDAQGS:EMBC7.555 M
Tandem Diabetes Care IncNASDAQGM:TNDM10.042 M
Sight Sciences IncNASDAQGS:SGHT10.427 M
Insulet CorporationNASDAQGS:PODD23.207 M
Edwards Lifesciences CorpNYSE:EW69.109 M

Metric Usage: EBITDA Forecast Consensus Standard Deviation

Hide this widget
ebitda_proj_stdev
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EBITDA Forecast Consensus Standard Deviation in the forecast category include:

View Full List

Search for metric or datapoint

EBITDA Forecast Consensus Standard Deviation

Standard deviation in forecasted EBITDA.

Definition of EBITDA Forecast Consensus Standard Deviation

Hide this widget
Standard deviation in forecasted EBITDA.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0 K75 M150 M285.4 M2006001,000

The chart above depicts the distribution of ebitda forecast consensus standard deviation for companies operating in the Healthcare sector in the Developed economic region. Over 1,510 companies were considered in this analysis, and 1,481 had meaningful values. The average ebitda forecast consensus standard deviation of companies in the sector is 11.355 M with a standard deviation of 31.447 M.

Insulet Corporation's EBITDA Forecast Consensus Standard Deviation of 23.207 M ranks in the 87.0% percentile for the sector. The following table provides additional summary stats:

EBITDA Forecast Consensus Standard Deviation In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,511
Included Constituents1,481
Min0 K
Max284.8 M
Median7.368 K
Mean11.355 M
Standard Deviation31.447 M

You can find companies with similar ebitda forecast consensus standard deviation using this stock screener.

All rights reserved. Terms Of Use